- Home
- ASND vs RCM Comparison
ASND vs RCM Comparison
Compare ASND & RCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- RCM
- Stock Information
- Founded
- ASND 2006
- RCM 2003
- Country
- ASND Denmark
- RCM United States
- Employees
- ASND N/A
- RCM N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- RCM Other Consumer Services
- Sector
- ASND Health Care
- RCM Consumer Discretionary
- Exchange
- ASND Nasdaq
- RCM Nasdaq
- Market Cap
- ASND 7.3B
- RCM 6.0B
- IPO Year
- ASND 2015
- RCM 2010
- Fundamental
- Price
- ASND $126.51
- RCM $14.30
- Analyst Decision
- ASND Strong Buy
- RCM Buy
- Analyst Count
- ASND 13
- RCM 15
- Target Price
- ASND $191.77
- RCM $15.30
- AVG Volume (30 Days)
- ASND 422.4K
- RCM 2.7M
- Earning Date
- ASND 11-14-2024
- RCM 11-05-2024
- Dividend Yield
- ASND N/A
- RCM N/A
- EPS Growth
- ASND N/A
- RCM N/A
- EPS
- ASND N/A
- RCM N/A
- Revenue
- ASND $365,187,374.00
- RCM $2,463,700,000.00
- Revenue This Year
- ASND $10.30
- RCM $14.10
- Revenue Next Year
- ASND $90.02
- RCM $14.39
- P/E Ratio
- ASND N/A
- RCM N/A
- Revenue Growth
- ASND 115.54
- RCM 11.36
- 52 Week Low
- ASND $90.13
- RCM $8.87
- 52 Week High
- ASND $161.00
- RCM $15.12
- Technical
- Relative Strength Index (RSI)
- ASND 46.41
- RCM 72.28
- Support Level
- ASND $124.11
- RCM $14.14
- Resistance Level
- ASND $129.86
- RCM $14.30
- Average True Range (ATR)
- ASND 5.50
- RCM 0.02
- MACD
- ASND 0.28
- RCM -0.00
- Stochastic Oscillator
- ASND 56.59
- RCM 85.71
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
About RCM R1 RCM Inc.
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.